A highly sensitive electrochemical biosensor for phenol derivatives using a graphene oxide-modified tyrosinase electrode.

Bioelectrochemistry

School of Chemical Engineering, University of Science and Technology Liaoning, 185 Qianshan Middle Road, High-tech zone, Anshan, Liaoning 114051, China. Electronic address:

Published: August 2018

The fabrication, characterization and analytical performance were investigated for a phenol biosensor based on the covalent bonding of tyrosinase (TYR) onto a graphene oxide (GO)-modified glassy carbon electrode (GCE) via glutaraldehyde (GA). The surface morphology of the modified electrode was studied by atomic force microscope (AFM) and field-emission scanning electron microscopy (FE-SEM). The fabricated TYR/GA/GO/GCE biosensor showed very good stability, reproducibility, sensitivity and practical usage. The catechol biosensor exhibited a wide sensing linear range from 5×10M to 5×10M, a lower detection limit of 3×10M, a current maximum (I) of 65.8μA and an apparent Michaelis constant (K) of 169.9μM.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioelechem.2018.04.003DOI Listing

Publication Analysis

Top Keywords

highly sensitive
4
sensitive electrochemical
4
biosensor
4
electrochemical biosensor
4
biosensor phenol
4
phenol derivatives
4
derivatives graphene
4
graphene oxide-modified
4
oxide-modified tyrosinase
4
tyrosinase electrode
4

Similar Publications

Background: Patients with estrogen receptor (ER)-positive breast cancer (BC) can be treated with endocrine therapy targeting ER, however, metastatic recurrence occurs in 25% of the patients who have initially been treated. Secreted proteins from tumors play important roles in cancer metastasis but previous methods for isolating secretory proteins had limitations in identifying novel targets.

Methods: We applied an in situ secretory protein labeling technique using TurboID to analyze secretome from tamoxifen-resistant (TAMR) BC.

View Article and Find Full Text PDF

A machine learning model accurately identifies glycogen storage disease Ia patients based on plasma acylcarnitine profiles.

Orphanet J Rare Dis

January 2025

Laboratory of Metabolic Diseases, Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Postbus, Groningen, 30001 - 9700 RB, the Netherlands.

Background: Glycogen storage disease (GSD) Ia is an ultra-rare inherited disorder of carbohydrate metabolism. Patients often present in the first months of life with fasting hypoketotic hypoglycemia and hepatomegaly. The diagnosis of GSD Ia relies on a combination of different biomarkers, mostly routine clinical chemical markers and subsequent genetic confirmation.

View Article and Find Full Text PDF

Diagnostic performance of prehospital EFAST in predicting CT scan injuries in severe trauma patients: a multicenter cohort study.

Eur J Trauma Emerg Surg

January 2025

Department of Emergency Medicine, Assistance publique des hôpitaux de Marseille (APHM), Marseille University, Timone University Hospital, Marseille, France.

Background: The early mortality of trauma patients, mainly from hemorrhagic shock, raises interest in detecting the presence of non-exteriorized bleeding. Intra-hospital EFAST (Extended Focused Assessment with Sonography for Trauma) has demonstrated its utility in the assessment and management of severe trauma patients (STP). However, there is a lack of data regarding the diagnostic performance of prehospital EFAST (pEFAST).

View Article and Find Full Text PDF

This research investigates the pulp and paper industry's transition to sustainability by valorizing unused roadside and natural grasses for paper production. Large-scale production from residual grass poses multifaceted challenges, requiring collaboration across stakeholders, from biomass collection to manufacturing. To understand key drivers and barriers within this complex system, experts from various fields, including local farmers, researchers, policymakers, and industry executives were interviewed, leading to the development of a Fuzzy Cognitive Map (FCM).

View Article and Find Full Text PDF

Suppression of epileptic seizures by transcranial activation of K-selective channelrhodopsin.

Nat Commun

January 2025

Shenzhen Key Laboratory of Gene Regulation and Systems Biology, and Brain Research Center, Department of Neuroscience, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.

Optogenetics is a valuable tool for studying the mechanisms of neurological diseases and is now being developed for therapeutic applications. In rodents and macaques, improved channelrhodopsins have been applied to achieve transcranial optogenetic stimulation. While transcranial photoexcitation of neurons has been achieved, noninvasive optogenetic inhibition for treating hyperexcitability-induced neurological disorders has remained elusive.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!